Growing community of inventors

London, United Kingdom

Simon Mutton

Average Co-Inventor Count = 9.47

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Simon MuttonJeffrey McKenna (2 patents)Simon MuttonPaul Wright (2 patents)Simon MuttonMahbub Ahmed (2 patents)Simon MuttonJoseph McKenna (2 patents)Simon MuttonAlexander Ashall-Kelly (2 patents)Simon MuttonLouisa Gueritz (2 patents)Simon MuttonRakesh Parmar (2 patents)Simon MuttonGraham Charles Bloomfield (1 patent)Simon MuttonJon Shepherd (1 patent)Simon MuttonJon Sheperd (1 patent)Simon MuttonJeffrey Mckenna (0 patent)Simon MuttonJoseph Mckenna (0 patent)Simon MuttonSimon Mutton (2 patents)Jeffrey McKennaJeffrey McKenna (13 patents)Paul WrightPaul Wright (8 patents)Mahbub AhmedMahbub Ahmed (7 patents)Joseph McKennaJoseph McKenna (5 patents)Alexander Ashall-KellyAlexander Ashall-Kelly (2 patents)Louisa GueritzLouisa Gueritz (2 patents)Rakesh ParmarRakesh Parmar (2 patents)Graham Charles BloomfieldGraham Charles Bloomfield (12 patents)Jon ShepherdJon Shepherd (1 patent)Jon SheperdJon Sheperd (1 patent)Jeffrey MckennaJeffrey Mckenna (0 patent)Joseph MckennaJoseph Mckenna (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (2 from 3,923 patents)


2 patents:

1. 9359381 - Tricyclic compounds for inhibiting the CFTR channel

2. 9303035 - Substituted pyrazino[1',2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channel

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…